This program project grant is focused on the etiology and prevention of oral cancer. While tobacco and alcohol consumption are clearly the major risk factors for this disease, other factors such as diet are also clearly involved. The purpose of this proposal is to address important and unanswered questions regarding the etiology of oral cancer and to develop preventive strategies based on this information. A major strength of this research is its interdisciplinary, yet highly integrated design with projects areas including epidemiology, snuff carcinogenicity and toxicity, laboratory studies on chemoprevention and mechanism, and primary prevention studies involving health education in children. In addition, all research projects have are focused on an ultimate of cancer prevention. Some of the major areas being addressed include: the role of tobacco-specific carcinogens and toxicants in snuff carcinogenicity; the development of new model systems for testing potential chemopreventive agents; the efficacy of nutritionally-bound cocktails including Se-containing compounds as chemopreventive agents, and the role of glutathione depletion as a risk factor for oral cancer and a possible central mechanism for effects in alcohol consumption and nutrient deficiencies. The studies include a multi-disciplinary team of investigators with a long history of collaboration in the area of disease prevention. Altogether the results from these studies should provide key information on the prevention of oral cancers based upon a multi-dimensional approach of chemoprevention, early health education, and regulation of tobacco products.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Program Projects (P01)
Project #
3P01DE013222-02S1
Application #
6352325
Study Section
Special Emphasis Panel (ZDE1 (27))
Program Officer
Sandberg, Ann
Project Start
1999-09-30
Project End
2002-08-31
Budget Start
2000-09-01
Budget End
2001-08-31
Support Year
2
Fiscal Year
2000
Total Cost
$168,265
Indirect Cost
Name
Institute for Cancer Prevention
Department
Type
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Schwartz, Joel L; Brunnemann, Klaus D; Adami, Alexander J et al. (2010) Brand specific responses to smokeless tobacco in a rat lip canal model. J Oral Pathol Med 39:453-9
Huang, Zhishan; Pinto, John T; Deng, Haiteng et al. (2008) Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol 75:2234-44
Huang, Zhishan; Komninou, Despina; Kleinman, Wayne et al. (2007) Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. Int J Cancer 120:1396-401
Guttenplan, Joseph B; Spratt, Thomas E; Khmelnitsky, Michael et al. (2004) Effects of 3H-1,2-dithiole-3-thione, 1,4-phenylenebis(methylene)selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice. Mutat Res 559:199-210
Schwartz, Joel L; Muscat, Joshua E; Baker, Vikki et al. (2003) Oral cytology assessment by flow cytometry of DNA adducts, aneuploidy, proliferation and apoptosis shows differences between smokers and non-smokers. Oral Oncol 39:842-54
Guttenplan, Joseph B; Kosinska, Wieslava; von Pressentin, Marcia d M et al. (2002) Effects of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and vitamin E on 4-nitroquinoline-N-oxide (4-NQO)-induced mutagenesis in lacZ mouse upper aerodigestive tissue. Mutat Res 518:85-93
Brunnemann, K D; Qi, J; Hoffmann, D (2002) Chemical profile of two types of oral snuff tobacco. Food Chem Toxicol 40:1699-703
El-Bayoumy, K (2001) The protective role of selenium on genetic damage and on cancer. Mutat Res 475:123-39
Hoffmann, D; Hoffmann, I; El-Bayoumy, K (2001) The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 14:767-90
Ghose, A; Fleming, J; El-Bayoumy, K et al. (2001) Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways. Cancer Res 61:7479-87

Showing the most recent 10 out of 12 publications